MAP kinases in the immune response.

MAP kinases are among the most ancient signal transduction pathways and are widely used throughout evolution in many physiological processes. In mammalian species, MAP kinases are involved in all aspects of immune responses, from the initiation phase of innate immunity, to activation of adaptive immunity, and to cell death when immune function is complete. In this review, we summarize recent progress in understanding the function and regulation of MAP kinase pathways in these phases of immune responses.

[1]  W. M. Weaver,et al.  Two essential regulatory elements in the human interferon gamma promoter confer activation specific expression in T cells , 1993, The Journal of experimental medicine.

[2]  Kazuhito Yamamoto,et al.  BCL-2 Is Phosphorylated and Inactivated by an ASK1/Jun N-Terminal Protein Kinase Pathway Normally Activated at G2/M , 1999, Molecular and Cellular Biology.

[3]  J. Miyoshi,et al.  Structure and transforming potential of the human cot oncogene encoding a putative protein kinase , 1991, Molecular and cellular biology.

[4]  M. Rincón.  MAP-kinase signaling pathways in T cells. , 2001, Current opinion in immunology.

[5]  F. Martinon,et al.  MyD88, an Adapter Protein Involved in Interleukin-1 Signaling* , 1998, The Journal of Biological Chemistry.

[6]  C. Janeway,et al.  ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway. , 1999, Genes & development.

[7]  M. Nussenzweig,et al.  TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival. , 1997, Immunity.

[8]  R. Flavell,et al.  Reprogramming the signalling requirement for AP-1 (activator protein-1) activation during differentiation of precursor CD4+ T-cells into effector Th1 and Th2 cells. , 1997, Genes and function.

[9]  K. Anderson,et al.  Toll signaling pathways in the innate immune response. , 2000, Current opinion in immunology.

[10]  R. Flavell,et al.  Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2. , 1998, Immunity.

[11]  M. Su,et al.  Interferon‐γ expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway , 1998, The EMBO journal.

[12]  R. Flavell,et al.  GADD45gamma mediates the activation of the p38 and JNK MAP kinase pathways and cytokine production in effector TH1 cells. , 2001, Immunity.

[13]  A. Mondino,et al.  Blocked Signal Transduction to the ERK and JNK Protein Kinases in Anergic CD4+ T Cells , 1996, Science.

[14]  H. Enslen,et al.  T Cells + but Not CD 4 + Apoptosis of CD 8 Kinase In Vivo Selectively Induces Activation of p 38 Mitogen-Activated Protein , 1999 .

[15]  D. Williams,et al.  Role of the guanosine triphosphatase Rac2 in T helper 1 cell differentiation. , 2000, Science.

[16]  M. Karin,et al.  JNK2 and IKKbeta are required for activating the innate response to viral infection. , 1999, Immunity.

[17]  G. Kollias,et al.  TNF-α Induction by LPS Is Regulated Posttranscriptionally via a Tpl2/ERK-Dependent Pathway , 2000, Cell.

[18]  T. Aune,et al.  Regulation of the activity of IFN-gamma promoter elements during Th cell differentiation. , 1998, Journal of immunology.

[19]  L. Glimcher,et al.  Lineage commitment in the immune system: the T helper lymphocyte grows up. , 2000, Genes & development.

[20]  S. Akira,et al.  Unresponsiveness of MyD88-deficient mice to endotoxin. , 1999, Immunity.

[21]  M. Karin,et al.  Mammalian MAP kinase signalling cascades , 2001, Nature.

[22]  S. Akira,et al.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. , 1999, Journal of immunology.

[23]  Melanie Allen,et al.  Deficiency of the Stress Kinase P38α Results in Embryonic Lethality , 2000, The Journal of Experimental Medicine.

[24]  M. Kaplan,et al.  The p38 Mitogen-Activated Protein Kinase Is Required for IL-12-Induced IFN-γ Expression1 , 2000, The Journal of Immunology.

[25]  H. Saito,et al.  A Family of Stress-Inducible GADD45-like Proteins Mediate Activation of the Stress-Responsive MTK1/MEKK4 MAPKKK , 1998, Cell.

[26]  M. Karin,et al.  c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. , 2001, The Journal of clinical investigation.

[27]  S. Akira,et al.  A Toll-like receptor recognizes bacterial DNA , 2000, Nature.

[28]  Y. Ip,et al.  A JNK signal transduction pathway that mediates morphogenesis and an immune response in Drosophila. , 1996, Genes & development.

[29]  Zhi-Min Yuan,et al.  Translocation of SAPK/JNK to Mitochondria and Interaction with Bcl-xL in Response to DNA Damage* , 2000, The Journal of Biological Chemistry.

[30]  W. Ouyang,et al.  IL-18–stimulated GADD45β required in cytokine-induced, but not TCR-induced, IFN-γ production , 2001, Nature Immunology.

[31]  S. Akira,et al.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.

[32]  E. Wagner,et al.  C-Jun Nh2-Terminal Kinase (Jnk)1 and Jnk2 Have Similar and Stage-Dependent Roles in Regulating T Cell Apoptosis and Proliferation , 2001, The Journal of experimental medicine.

[33]  A. Gurney,et al.  Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling , 1998, Nature.

[34]  P. Feng,et al.  IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. , 1997, Science.

[35]  M. Bachmann,et al.  Selection of the T cell repertoire. , 1999, Annual review of immunology.

[36]  Z. Cao,et al.  MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. , 1997, Immunity.

[37]  R. Davis,et al.  Signal Transduction by the JNK Group of MAP Kinases , 2000, Cell.

[38]  A. Weiss,et al.  Signal transduction by the TCR for antigen. , 2000, Current opinion in immunology.

[39]  M. Gaestel,et al.  MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis , 1999, Nature Cell Biology.

[40]  R. Flavell,et al.  c-Jun NH2-Terminal Kinase Inhibits Targeting of the Protein Phosphatase Calcineurin to NFATc1 , 2000, Molecular and Cellular Biology.

[41]  Crafford A. Harris,et al.  Interleukin (IL)-1 Receptor–associated Kinase (IRAK) Requirement for Optimal Induction of Multiple IL-1 Signaling Pathways and IL-6 Production , 1998, The Journal of experimental medicine.

[42]  I. Mellman,et al.  Defective IL‐12 production in mitogen‐activated protein (MAP) kinase kinase 3 (Mkk3)‐deficient mice , 1999, The EMBO journal.

[43]  L. Glimcher,et al.  Tumor Necrosis Factor Receptor–Associated Factor (Traf)2 Represses the T Helper Cell Type 2 Response through Interaction with Nfat-Interacting Protein (Nip45) , 2001, The Journal of experimental medicine.

[44]  D. Green,et al.  Withdrawal of Survival Factors Results in Activation of the JNK Pathway in Neuronal Cells Leading to Fas Ligand Induction and Cell Death , 1999, Molecular and Cellular Biology.

[45]  R. Flavell,et al.  JNK1 Is Required for T Cell-Mediated Immunity Against Leishmania major Infection1 , 2000, The Journal of Immunology.

[46]  C. Janeway,et al.  MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. , 1998, Molecular cell.

[47]  Y. Ip,et al.  A Conserved p38 Mitogen-Activated Protein Kinase Pathway Regulates Drosophila Immunity Gene Expression , 1998, Molecular and Cellular Biology.

[48]  R. Ulevitch,et al.  Emerging targets for anti-inflammatory therapy , 1999, Nature Cell Biology.

[49]  H. Schaeffer,et al.  Mitogen-Activated Protein Kinases: Specific Messages from Ubiquitous Messengers , 1999, Molecular and Cellular Biology.

[50]  P. Fields,et al.  Blocked Ras Activation in Anergic CD4+ T Cells , 1996, Science.

[51]  P. Rakic,et al.  The Jnk1 and Jnk2 Protein Kinases Are Required for Regional Specific Apoptosis during Early Brain Development , 1999, Neuron.

[52]  R. Flavell,et al.  Signal transduction by MAP kinases in T lymphocytes , 2001, Oncogene.

[53]  R. Flavell,et al.  Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for tumor necrosis factor-induced cytokine expression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Zhaodan Cao,et al.  TRAF6 is a signal transducer for interleukin-1 , 1996, Nature.

[55]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[56]  W. Paul,et al.  Lymphocyte responses and cytokines , 1994, Cell.

[57]  R. Flavell,et al.  Defective T cell differentiation in the absence of Jnk1. , 1998, Science.

[58]  T. Akiyama,et al.  Identification and characterization of protein products of the cot oncogene with serine kinase activity. , 1991, Oncogene.

[59]  L. Zon,et al.  SEK1 deficiency reveals mitogen-activated protein kinase cascade crossregulation and leads to abnormal hepatogenesis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[60]  D. Green,et al.  DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. , 1998, Molecular cell.

[61]  W. M. Weaver,et al.  The Proximal Regulatory Element of the Interferon-γ Promoter Mediates Selective Expression in T Cells* , 1996, The Journal of Biological Chemistry.

[62]  R. Flavell,et al.  Regulation of c-Jun NH2-terminal Kinase ( Jnk) Gene Expression during T Cell Activation , 2000, The Journal of experimental medicine.

[63]  G. Kollias,et al.  Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. , 1999, Immunity.

[64]  B. Jaffee,et al.  Inhibition of mitogen-activated protein kinase kinase blocks T cell proliferation but does not induce or prevent anergy. , 1998, Journal of immunology.

[65]  J. Woodgett,et al.  Cross‐linking CD40 on B cells preferentially induces stress‐activated protein kinases rather than mitogen‐activated protein kinases. , 1996, The EMBO journal.

[66]  S. Morony,et al.  TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. , 1999, Genes & development.

[67]  I. Macara,et al.  JNK, but not MAPK, activation is associated with Fas‐mediated apoptosis in human T cells , 1996, European journal of immunology.

[68]  C. Janeway,et al.  Innate Immunity: The Virtues of a Nonclonal System of Recognition , 1997, Cell.

[69]  E. Wagner,et al.  Jun N-terminal kinase 2 modulates thymocyte apoptosis and T cell activation through c-Jun and nuclear factor of activated T cell (NF-AT). , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[70]  M. Mann,et al.  Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation. , 2000, Genes & development.

[71]  J. Pouysségur,et al.  Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. , 1999, Science.

[72]  R. Flavell,et al.  MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. , 2001, Genes & development.

[73]  L. Larivière,et al.  Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4) , 1999, The Journal of experimental medicine.

[74]  T. Aune,et al.  Differential transcription directed by discrete gamma interferon promoter elements in naive and memory (effector) CD4 T cells and CD8 T cells , 1997, Molecular and cellular biology.

[75]  G. Koretzky,et al.  Stress-Induced Fas Ligand Expression in T Cells Is Mediated through a MEK Kinase 1-Regulated Response Element in the Fas Ligand Promoter , 1998, Molecular and Cellular Biology.

[76]  J. Ihle,et al.  Gadd45γ Is Dispensable for Normal Mouse Development and T-Cell Proliferation , 2001, Molecular and Cellular Biology.

[77]  R. Flavell,et al.  The JNK Pathway Regulates the In Vivo Deletion of Immature CD4+CD8+ Thymocytes , 1998, The Journal of experimental medicine.

[78]  E. Wagner,et al.  JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development , 1999, Current Biology.

[79]  George Kollias,et al.  Interleukin‐10 targets p38 MAPK to modulate ARE‐dependent TNF mRNA translation and limit intestinal pathology , 2001, The EMBO journal.

[80]  R. Flavell,et al.  JNK is required for effector T-cell function but not for T-cell activation , 2000, Nature.

[81]  S. Akira,et al.  Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. , 1998, Immunity.

[82]  R. Flavell,et al.  Control of T Helper Cell Differentiation--in Search of Master Genes , 2000, Science's STKE.

[83]  D. Green,et al.  The c-Jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by up-regulating Fas ligand expression. , 1998, Journal of immunology.

[84]  S. Akira,et al.  The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 , 2001, Nature.

[85]  R. Perlmutter,et al.  T cell antigen receptor-mediated activation of the Ras/mitogen-activated protein kinase pathway controls interleukin 4 receptor function and type-2 helper T cell differentiation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[86]  L. Glimcher,et al.  Decreased immediate inflammatory gene induction in activating transcription factor-2 mutant mice. , 2001, International immunology.

[87]  M. Karin,et al.  Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. , 1998, Science.

[88]  T. Pawson,et al.  Disruption of T cell signaling networks and development by Grb2 haploid insufficiency , 2001, Nature Immunology.